|
| Status |
Public on Sep 18, 2017 |
| Title |
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by high throughput sequencing Methylation profiling by high throughput sequencing Other
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation missing |
Has this study been published? Please login to update or notify GEO. |
| |
| Submission date |
Mar 16, 2016 |
| Last update date |
May 15, 2019 |
| Contact name |
James Bradner |
| E-mail(s) |
bradner_computation@dfci.harvard.edu
|
| Organization name |
Dana-Farber Cancer Institute
|
| Department |
Medical Oncology
|
| Lab |
Bradner Lab
|
| Street address |
450 Brookline
|
| City |
Boston |
| State/province |
MA |
| ZIP/Postal code |
02215 |
| Country |
USA |
| |
|
| Platforms (1) |
| GPL18573 |
Illumina NextSeq 500 (Homo sapiens) |
|
| Samples (58)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE79253 |
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [RNA-seq] |
| GSE79271 |
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] |
| GSE79288 |
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [ChIP-seq] |
|
| Relations |
| BioProject |
PRJNA315412 |